List of Publications

January to December 2015

ABDULKARIM, B

Jung K, Sabri S, Hanson J, Xu Y, Wang YW, Lai R, Abdulkarim BS. Elevated ARG1 expression in primary

monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast

cancer patients. Cancer Biol Ther 2015; 16(9): 1281-8.

Azoulay M, Santos F, Souhami L, Panet-Raymond V, Petrecca K, Owen S, Guiot MC, Patyka M, Sabri S,

Shenouda G, Abdulkarim B. Comparison of radiation regimens in the treatment of Glioblastoma

multiforme: results from a single institution. Radiat Oncol 2015 Apr 26; 10:106.

Jung K, Gupta N, Wang P, Lewis JT, Gopal K, Wu F, Ye X, Alshareef A, Abdulkarim BS, Douglas DN, Kneteman

NM, Lai R. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by

its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Oncotarget 2015 Apr 30; 6(12):

10366-73.

AJISE, O

F. Brimo, S. Dauphin-Pierre, A. Aprikian, W. Kassouf, S. Tanguay, O. Ajise, C. Dongo, LR. Bégin. Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant. Hum Pathol. 2015 Oct; 46(10):1506-13.

ALAMELDIN, M

Schiavi A, Lavigne J, Turcotte R, Kasprzak L, Dumas N, Chong G, Freeman C, Alameldin M, Galiatsatos P, Palma L, Foulkes WD. Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma. Curr Oncol. 2015 Oct; 22(5):317-25.

ALBRECHT, S.

Kwan S, Boudes E, Gilbert G, Saint-Martin C, Albrecht S, Shevell M, Wintermark P. Injury to the cerebellum

in term asphyxiated newborns treated with hypothermia. Am J Neuroradiol 36: 1542-9 2015.

Fontebasso AM, Shirinian M, Khuong-Quang DA, Bechet D, Gayden T, Kool M, De Jay N, Jacob K, Gerges

N, Hutter B, Seker-Cin H, Witt H, Montpetit A, Brunet S, Lepage P, Bourret G, Klekner A, Bognar L, Hauser

P, Garami M, Farmer JP, Montes JL, Atikinson J, Lambert S, Kwan T, Korshunov A, Tabori U, Collins VP,

Albrecht S, Faury D, Pfister SM, Paulus W, Hasselblatt M, Jones DT, Jabado N. Non-random aneuploidy

specifies subgroups of pilocytic astrocytoma and correlates with older age. Oncotarget 13: 31844-56,

2015.

Glikstein R, Biswas A, Mohr G, Albrecht S. Supratentorial paraventricular schwannoma. Neuroradiol J 28:

46-50 2015.

Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P,

Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, Pimentel J, Chan AJ, Somers GR, Zielenska M, Faria CC< Roque

L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobagyi T, Bognar L, Wilson

B, Hukin J, Carret AS, Van Meter TE, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat

DD, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay DA, Fleming AJ, Lulla RR,

Fangusaro JR, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai MA, Montpetit A, Stephens D,

Grundy RG, Schuller U, Nicolaides T, Tihan T, Phillips J, Taylor MD, Rutka JT, Dirks P, Bader GD, Warmuth-

Metz M, Rutkowski S, Pietsch T, Judkins AR, Jabado N, Bouffet E, Huang A. Molecular subgroups of atypical

teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet

Oncol 16: 569-82, 2015.

ALEYNIKOVA, O

Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliococco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, AAleynikova O, Basik M. The estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Res. 2015 Oct 15:75(20): 4351-63. Blouin MJ, Bazile M, Birman E, Zakikhani M, Florinova L, Aleynikova O, Powell DR, Pollak M. Germ line knockout of IGFP-3 reveals influences of the gene on mammary gland neoplasia. Breast Cancer Res. Treat 2015 Feb: 149(3): 577-85. Castellsagué E, Liu J, Volenik A, Giroux S, Gagné R, Maranda B, Roussel-Jobin A, Latreille J, Laframboise R, Palma L, Kasprzak L, Marcus VA, Beguet M,. Nolet S, El-Haffaf Z, Australie K, Gologan A, Aleynikova O, Oros-Klein K, Greenwood C, Mes-Masson AM, Provencher D, Tischkowitz M, Chong G, Rousseau F, Foulkes WD. Chracterization of a novel founder MSH6 mutation causing Lynch syndrome in the French-Canadian population. Clin Genet. 2015 Jun: 87(6):536-42.

AMRE, R Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J, Amre R et al. Decreased PCSK9 expression in human hepatocellular carcinoma. BMC Gastroenterology 2015; 15:176. Smith AL, Bascunana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, et al. Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Current Oncology 2015; 22:113-121. ARSENEAU, J De Kock L, Druker H, Weber E, Hamel N, Traubici J, Malkin D, Arseneau J, Stewart CJ, Bouron-Dal Soglio D,

Priest JR, Foulkes WD. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1

syndrome. Hum Pathol 2015 Jun; 46(6): 917-22.

AUGER, M Kanber Y, Charobonneau M, Auger M. Pap smears with glandular cell abnormalities: are they detected by

rapid prescreening? Cancer Cytopathol 2015; 123: 739-744.

Tabatabai ZL, Auger M, Kurtycz D, Laser A, Souers R, Laucirica R, Barkan G, Crothers B, Khalbuss W.

Performance characteristics of adenoid cystic carcinoma of the salivary gland in fine needle aspirates:

Results from the CAP non-gynecologic cytology program. Arch Pathol Lab Med 2015; 139: 1525-1530.

Brimo F, Auger M. The atypical urothelial category in the Paris System: strengthening the Achilles tendon.

Cancer Cytopathol 2015, epub Dec 21, 2015.

Barkan GA, Laucirica R, Padmanabhan V, Auger M, Khalbuss W, Souers R, Moriarty AT. Performance

characteristics of Urinary Tract Cytology: Observations from the College of American Pathologists

Interlaboratory Comparison Program in Nongynecologic Cytopathology (CAP NGC). Arch Pathol Lab Med

2015; 139: 1009-1013.

Kanber Y, Auger M. Granulomatous thyroiditis diagnosed by fine needle aspiration cytology: A case report

with review of other benign entities. Pathology Case Reviews 2015; 20: 105-109.

Tabatabai L, Moriarty AT, Nayar R, Auger M, Kurtycz DFI, Thomas N, Laucirica R, Padmanabhan V, Souers

RJ, Schwartz MR, Fraig M. Do Liquid-Based Preparations of Pulmonary Bronchial Brushing Specimens

Perform Differently from Classically Prepared Cases for the Diagnosis of Malignancies? Observations from

the College of American Pathologists Nongynecologic Cytology Interlaboratory Comparison Program. Arch

Pathol Lab Med 2015; 139:178-183.

Auger M, Islam S, Weir M. A historical step for advanced cytopathology training in Canada. Cancer

Cytopathology 2015; 123: 7-9.

BAGLOLE, CJ Sarill M, Zago M, Sheridan JA, Nair P, Matthews J, Gomez A, Lucie Roussel, Simon Rousseau, Hamid Q, Eidelman DH and Baglole CJ. The aryl hydrocarbon receptor suppresses cigarette smoke-induced oxidative stress in association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1. Free Rad Biol Med. 89; 342-357, 2015. Nishioka M, Narayanan V, Dessalle K, Mogas A, Kyoh S, Lin T, Nair P, Baglole CJ, Eidelman DH, Ludwig MS and Hamid Q. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Respir Res. 16(1):72, 2015. Sheridan JA, Zago M, Nair P, Li PZ, Bourbeau J, Tan WC, Hamid Q, Eidelman DH, Benedetti AL and Baglole CJ. Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression. Respir Res. 16(1); 54, 2015. Thompson PA, Khatami M, Baglole CJ, Sun J, Harris S, Moon EY, Al-Mulla F, Al-Temaimi R, Brown D, Colacci A, Mondello C, Raju J, Ryan E, Woodrick J, Scovassi I, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Lowe L and Bisson WH. Environmental Immune Disruptors, Inflammation and Cancer Risk. Carcinogenesis. 36 (Supplement 1): S232-S253, 2015.

Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Ali AM, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, et al. Assessing the Carcinogenic Potential of Low Dose Exposures to Chemical Mixtures in the Environment: The Challenge Ahead. Carcinogenesis, 36 (Supplement 1), S254-S296, 2015. Van Dijk W, Tan W, Li P, Guo B, Li S, Benedetti A, Bourbeau J; CanCOLD Study Group: Aaron S, Chapman K, FitzGerald MJ, Goldstein R, Hernandez P, Maltais F, Marciniuk D, O'Donnell D, Sin D, Cowie R, Coxson H, Leipsic J, Hague C, Road J, Atherton J, Baglole C, Daskalopoulou S, Després J, Gershon A, Lavoie K, Miedinger D, Rabasa R, Wilchesky M, Andersen R, Doucet M, Evans J, Marra C, Kimoff J, Pare P, Hogg JC, Perrault H, Shatenstein B, Shell B, Taivassalo T, To T, Jabet C, Sedeno M. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 13(1): 41-8, 2015 [IF: 4.570]

BRIMO, F Florinova L, Xu B, Traboulsi S, Elmansi H, Tanguay S, Aprikian A, Kassouf W, Brimo F. Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study. World J Surg Oncol. 2015 Nov; 13:317. Brimo F. as part of the Cancer Genome Atlas Research Network Collaboration. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5; 163(4):1011-25. Sourial MW, Brimo F, Horn R, Andonian S. Genitourinary tuberculosis in North America: A rare clinical entity. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8)

Brimo F, Attallah C, Li G, Srigley JR. Cystic clear cell papillary renal cell carcinoma: is it related to multilocular clear cell cystic neoplasm of low malignant potential? Histopathology. (Available online, 2015 Aug 7). Brimo F, Dauphin-Pierre S, Aprikian A, Kassouf W, Tanguay S, Ajise O, Dongo C, Begin LR. Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant. Hum Pathol. 2015 Oct; 46(10):1506-13. Al-Qaoud T, Brimo F, Aprkian AG, Andonian S. BCG-related renal granulomas managed conservatively: A case series. Can Urol Assoc J. 2015 Mar-Apr; 9(3-4). Brimo F, Xu B, Kassouf B, Khaliji B, Charbonneau M, Nahal A, Kanber Y, Caglar D, Auger M. Urine cytology: does the number of atypical urothelial cells matter? A qualitative and quantitative study of 112 cases. JASC 2015; 4(4):232-238

Barayan GA, Aprikian AG, Hanley J, Kassouf W, Brimo F Bégin LR, Tanguay S.. Outcome of repeated

prostatic biopsy during active surveillance: implications for focal therapy. World J Urol. 2015 Sep;

33(9):1275-80

BURNIER, M

Zoroquiain P, Aldrees S, Logan P, Alkharashi M, Diaz ABT, Alghamdi S, Burnier MN. Gonadotropin-Releasing Hormone Receptor is expressed in Retinoblastoma. J Clin & Exper Pathol; 5:231; 2015. Couto C, Hurtado E, Faingold D, Demetrio C, Schlaen A, Zas M, Zarate J, Rosetti S, de Lima AP, Croxatto JO, Chiaradía P, Burnier MN. Atypical Bilateral Fuchs Uveitis: Diagnostic Challenges. Case Rep Ophthalmol. 2015. Sep 2; 6(3)284-8. Alghamdi SA, Zoroquiain P, Dias AB, Alhumaid SR, Aldrees S, Burnier MN Jr. Diagnostic Value of SOX-10 immunohistochemical staining for the detection of uveal melanoma. Ecancermedicalscience. 2015. Aug 20; 9 566. Zoroquiain P., Logan P, Bravo-Filho V., Vila N., Jabbour S, Orellana M.E., Burnier M.N. Diagnosing Pathological Prognostic Factors in Retinoblastoma: Correlation between traditional microscopy and digital slides. Ocul Oncol Pathol. 2015; 1(4) 259-265. Logan P, Bernabeu M, Ferreira A, Burnier MN Jr. Evidence for the role of Blue Light in the Development of Uveal Melanoma. J Opthalmol. 2015; 2015:386986 Orellana ME, Quezada C, Maloney SC, Antecka E, Balazsi M, Burnier MN Jr. Expression of SIRT 2 and SIRT 6 in Retinoblastoma. Ophthalmic Res. 2015 53(2) 100-8. Jagan L, Zoroquiain P, Bravo-Filho V, Logan P, Qutub M, Burnier MN Jr. Sebaceous adenomas of the eyelid and Muir-Torre Syndrome. Br J Ophthalmol.2015 Jul; 99(7):909-13.

CAGLAR, D Ibrahim B, Forest VI, Hier M, Mlynarek AM, Caglar D, Payne RJ. Completion thyroidectomy predicting bilateral disease. J Otolaryngol Head Neck Surg. 2015 Jun 16; 44:23.

CAMILLERI-BROET, S Dalmasso C, Carpentier W, Guettier C, Camilleri-Broët S, Borelli WV, Campos Dos Santos CR, Castaing D, Duclos-Vallée JC, Broët P. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma. BMC Cancer. 2015 Mar 14; 15:126.

CASE, B Case BW (2015): Epidemiology of malignant Pleural Mesothelioma in the Americas. IN: Malignant Pleural Mesothelioma: Present Status and Future Directions. Tommaso Claudio Mineo, editor: Bentham Science Publishers, pages 53-72.

FRASER, R Chung J, Lachapelle K, Wener E, Cartier R, DeVarennes B, Fraser R, Leask RL. Energy loss, a novel biomechanical parameter correlates with aortic aneurysm size and histopathologic findings. J Thorac Cardiovasc Surg 2015 148:1082-1089. Khasper A, Gruber JM, Fraser R, Discepola F,Semionov A. Review of Thoracic Imaging Finding Unique to Women. Canadian Association of Radiologists Journal 2015, Aug 66(3) 223-230.

GAO, ZH Ham B, Wang N, D’Costa Z, Bourdeau F, Auguste P, Illemann M, Eefsen RL, Hoyer-Hansen G, Vainer B, Fernandez MC, Evard M, Gao ZH, Brodt P. The TNF receptor 2 regulates the immunosuppressive microenvironment of hepatic metastases and promotes their growth. Cancer Res. 2015 Dec 15; 75(24):5235-47.

Chowdhury S, Grimm L, Gong YJK, Wang BX, Li B, Srikant CB, Gao ZH, Liu JL. Decreased 11ß-hydroxysteroid dehydrogenase 1 level and activity in murine pancreatic islets caused by insulin-like growth factor 1 overexpression. PLOS One 2015 Aug 25; 10(8):

Wang YW, Chen X, Gao JW, Zhang H, Ma RR, Gao ZH, Gao P. High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer. Oncotarget. 2015; 6(12):10646-10657.

Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/b-catenin pathway in human colon cancer cells. Biomedicine & Pharmacotherapy 2015 71: 46-52.

Li Y, Gao ZH, Qu XJ. The Adverse Effect of Sorafenib in Patients with Advanced Cancers. Basic & Clinical Pharmacology & Toxicology. 2015, 116(3):216-21.

Smith AL, Bascuñana C, Hall CA, Gao ZH et al. Establishment of a clinic-based pancreatic cancer and peri-ampullary tumor research registry in Quebec. Current Oncol. 2015 Apr 22(2): 113-21.

GOLOGAN, A Li L, Hamel N, Baker K, McGuffin MJ, Couillard M, Gologan A, Marcus VA, Chodirker B, Chudley A,

Stefanovici C, Durandy A, Hegele RA, Feng BJ, Goldgar DE, Zhu J, DeRosa M, Gruber SB, Wimmer K, Young

B, Chong G, Tishkowitz MD, Foulkes WD. A homozygous PMS2 founder mutation with an attenuated

constitutional mismatch repair deficiency phenotype. J Med Genet 2015 May;52(5):348-52.

Castellsaqué E, Liu J, Volenik A, Giroux S, Gagné R, Maranda B, Roussel-Jobin A, Latreille J, Laframboise R,

Palma L, Kasprzak L, Marcus VA, Brequet M, Nolet S, El-Haffaf Z, Australie K, Gologan A, Aleynikova O,

Oros-Klein K, Greenwood C, Mes-Masson AM, Provencher D, Tischkowitz M, Chong G, Rousseau F, Foulkes

WD. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian

population. Clin Genet 2015 Jun; 87(6): 536-42.

GUIOT, MC

M. Jermyn, K. Mok, J. Mercier, J. Desroches, J. Pichette, K. Saint-Arnaud, L. Bernstein, M-C. Guiot, K.

Petrecca, F. Leblond. Intraoperative brain cancer detection with Raman spectroscopy in humans. Science

Translational Medicine. 2015, 7,274.

Azoulay M., Snatos F., Souhami L., Panet-Raymond V., Petrecca K., Owen S., Guiot MC, Patyka M., Sabri

S., Shenouda G., Abdulkarim B. Comparison of radiation regimens in the treatment of Glioblastoma

multiforme: results from a single institution. Radiat Oncol. 2015, 10, 106.

Desroches J., Jermyn M., Mok K., Lemieux-Leduc C., Mercier J., St-Arnaud K., Urmey K., Guiot MC., Marple

E., Petrecca K., Leblond F. Characterization of a Raman spectroscopy probe system for intraoperative

brain tissue classification. Biomed Opt Express, 2015, 6 (7), 2380-97.

Alshami J., Guiot MC., Owen S., Kavan P., Gibson N., Solca F., Cseh A., Reardon DA., Myanza T. Afatinib,

an irreversible ErB family blocker with protacted temolozomide in recurrent glioblastoma: a case report.

Oncotarget 2015, 6 (32), 34030-7.

Lee MJ., Barker BM., Snarr BD., Gravelat FN., All Abdallah Q., Gavino C., Baistrocchi SR., Ostapska H., Xiao

T., Ralph B., Solis NV., Lehoux M., Baptista SD., thammahong A., Cerone RP., Kaminskyj SG., Guiot MC.,

lafge JP., Fontaine T., Vinh DC., Filler SG., Sheppard DC. The fungal exopolysaccharide

galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps.

PLoS Pathog, 2015, 11 (10).

Gavino C., Hamel N., Zeng JB., Legault C., Guiot MC., Chankowsky J., Lejtenyi D., Lemire M., Alarie I.,

Dufresne S., Boursiquot JN., McIntosh F., Langelier M., Berh MA., Sheppard DC., Foulkes WD., Vinh DC.

Impaired RASGRF/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians.

J Allergy Clin immunol. 2015, 15, 1354-8.

HAEGERT, D

Haegert DG. The definition of multiple sclerosis: implications for research. J Mult Scler 2 e105, 2015.

HALIOTIS, T Morin RD, Assouline S, Alcaide M, Mohajeri A, Johnston RL, Chong L, Grewal J, Yu S, Fornika D, Bushell K, Nielsen TH, Petrogiannis-Haliotis T, Crump M, Tosikyan A, Grande BM, Macdonald D, Rousseau C, Bayat M, Sesques P, Froment R, Albuquerque M, Monczak Y, Klein-Oros K, Greenwood C, Riazalhosseini Y, Arseneault M, Camlioglu E, Constantin AM, Pan-Hammarström Q, Peng R-J, Mann KK, Johnson NA. Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas. Clin Cancer Res (2015 Dec 8. Epub 2015 Dec 8) Marton A, Kezouh A, Petrogiannis-Haliotis T, Assouline S. Barriers to enrollment of patients with recurrent

diffuse large B-cell lymphoma (DLBCL) onto clinical trials. Leuk Lymphoma (2015, Feb 4): 1-9

HAMID, Q

Synder J, Rin Son A, hamid Q, Wang C, Lui Y, Sun W. Mesenchymal stem cell printing and process regulated

cell properties. Biofabrication 2015 Dec 22; 7(4):044106.

Corrigan CJ, Hamid Q, O’Heir RE, Wardlaw AJ. Farewell. Clin Exp Allergy 2015 Dec; 45(12): 1721-2.

Sarill M, Zago M, Sheridan JA, Nair P, Matthews J, Gomez A, Roussel L, Rousseau S, Hamid Q, Eidelman D,

Baglole CJ. The aryl hydrocarbon receptor suppresses cigarette-smoke-induced oxidative stress in

association with dioxin response element (DRE)-independent regulation of sulfiredoxin 1. Free Radic Biol

Med. 2015 Dec; 89:342-57.

Miller M, Beppu A, Rosenthal P, Pham A, Das S, Karta M, Song DJ, Vuong C, Doherty T, Croft M, Zuraw B,

Zhang X, Gao X, Aceves S, Chouiali F, Hamid Q, Broide DH. Fstl1 Promotes Asthmatic Airway Remodeling

by Inducing Oncostatin M. J Immunol 2015 Oct 15; 195(8): 3546-56.

Nishioka M, Venkatesan N, Dessalle K, Mogas A, Kyoh S, Lin TY Nair P, Baglole CJ, Eidelman DH, Ludwig

MS, Hamid Q. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in

cells from normal and COPD patients. Respir Res. 2015 Jun 18; 16:72.

Tan WC, Sin DD, Bourbeau J, Hernandez P, Chapman KR, Cowie R, FitzGerald JM, Marciniuk DD, Maltais F,

Buist AS, Road J, Hogg JC, Kirby M, Coxson H, Hague C, Leipsic J, O’Donnell DE, Aaron SD, CanCOLD

Collaborative Research Group. Characteristics of COPD in never-smokers and ever-smokers in the general

population: results from the CanCOLD study. Thorax 2015 Sep;70(9):822-9.

Sheridan JA, Zago M, Nair P, Li PZ, Bourbeau J, Tan WC, Hamid Q, Eidelman DH, Benedetti AL, Baglole CJ.

Decreased expression of the NF-kB family member RelB in lung fibroblasts from Smokers with and without

COPD potentiates cigarette smoke-induced COX-2 expression. Respir Res. 2015 May 6; 16:54

Hamid Q, Wang C, Synder J, Williams S, Liu Y, Sun W. Maskless fabrication of cell-laden microfluidic chips

with localized surface functionalization for the co-culture of cancer cells. Biofabrication 2015 Mar 2; 7(1):

015012.

KANBER, Y

Kanber Y, Charbonneau Y, Auger M. Pap smears with glandular cell abnormalities: Are they detected by

rapid prescreening? Cancer (Cancer Cytopathol) 2015; 123:739–744.

Kanber Y, Auger M. Granulomatous Thyroiditis Diagnosed by Fine-Needle Aspiration Cytology—A Case

Report With Review of Other Benign Thyroid Entities. Pathology Case Reviews. 2015; 20(3):105-109.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.Smith

AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D,

Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J,

Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P,

Zogopoulos G. Curr Oncol. 2015 Apr; 22(2):113-21.

Brimo F, Xu B, Kassouf W, Ahmadi-Kaliji B, Charbonneau M, Nahal A, Kanber Y, Caglar D, Auger M. Urine

cytology: does the number of atypical urothelial cells matter? A qualitative and quantitative study of 112

Cases. JASC 2015; 4(4)232.

KARAMCHANDANI, J

Wala SJ, Karamchandani JR, Saleeb R, Evans A, Ding Q, Ibrahim R, Jewett M, Pasic M, Finelli A, Pace K,

Lianidou E, Yousef GM. An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers

the role of focal adhesion and extracellular matrix pathways. Molecular Oncology. 2015 Oct; 9(8):1667-

77.

Mohammed AA, Rotondo F, Munoz DG, Kovacs K, Bilbao JM, Karamchandani JR, Di Ieva A, Cusimano MD.

Diagnostic and prognostic biomarkers of a sellar melanocytic tumor mimicking pituitary adenoma: Case

report and literature review. Pathology Research Practice 2015, 211(9): 682-687

Naseem M, Murray J, Hilton JF, Karamchandani J, Muradali D, Faragalla H, Polenz C, Han D, Bell DC,

Brezden-Masley C. Mammographic microcalcifications and breast cancer tumorigenesis: a radiologic-

pathologic analysis. BMC Cancer 2015 Apr 22; 15:307

Fathalla H, Cusimano M, Di Ieva A, Karamchandani J, Fung R, Kovacs K. Osteomalacia Inducing Tumors of

the Brain; a case report, review and a hypothesis. World Neurosurgery 2015 Jul; 84(1): 189 e1-5

Treacy AD, Karamchandani JR, Streutker CJ, Grin A HER2 Genetic Heterogeneity in Gastric Cancer:

Evaluation According to the College of American Pathologists Breast Cancer Criteria. Applied

Immunohistochemistry and Molecular Morphology 2015 Oct; 23(9): 628-32.

Karamchandani JR, Gabril MY, Ibrahim R, Scorilas A, Filter E, Finelli A, Lee JY, Ordon M, Pasic M, Romaschin

AD, Yousef GM. Profilin-1 expression is associated with high grade and stage and decreased disease-free

survival in renal cell carcinoma. Hum Pathol. 2015 May; 46(5):673-80

LAVOIE , J Ulsh BA, Dolling J, Lavoie J, Mitchel REJ and Boreham DR. Chromosome damage caused by accidental chronic whole-body gamma radiation exposure in Thailand. Dose Response Nov 12; 13(4): (2015). MARCUS, V Castellsague E, Liu J, Volenik A, Giroux S, Gagne R, Maranda B, Roussel-Jobin A, Latreille J, Laframboise R, Palma L, Kasprzak L, Marcus VA, Breguet M, Nolet S, El-Haffaf Z, Australie K, Gologan A, Aleynikova O, Oros-Klein K, Greenwood C, Mes-Masson AM, Provencher D, Tischkowitz M, Chong G, Rousseau F, Foulkes WD. Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. Clin Genet 2015; 87: 536-42. Li L, Hamel N, Baker K, McGuffin MJ, Couillard M, Gologan A, Marcus VA, Chodirker B, Chudley A, Stefanovici C, Durandy A, Hegele RA, Feng BJ, Goldgar DE, Zhu J, De Rosa M, Gruber SB, Wimmer K, Young B, Chong G, Tischkowitz MD, Foulkes WD. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype. J Med Genet 2015; 52: 348-352. Lobaton T, Bessissow T, De Hertogh G, Lemmens B, Maedler C, Van Assche G, Vermeire S, Bisschops R, Rutgeerts P, Bitton A, Afif W, Marcus V, Ferrante M. The Modified Mayo Endoscopic Score (MMES): A New

Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients. J Crohns Colitis 2015; 9: 846-852. Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J, Amre R, Tabaries S, Hassanain M, Seidah NG, Maluccio M, Siegel P, Metrakos P. Decreased PCSK9 expression in human hepatocellular carcinoma. BMC Gastroenterol 2015; 15: 176.

METRAKOS, P

Abualhassan N, Aljiffry M, Thalib L, Coussa R, Metrakos P, Hassanain M. Saudi J. Post-transplant venous thromboembolic events and their effect on graft survival. Kidney Dis Transpl. 2015 Jan; 26(1): 1-5. Stutz M, Mamo A, Valenti D, Hausvater A, Cabrera T, Metrakos P, Chaudhury P, Steacy G, Garoufalis E, Kavan P. Real-Life Report on Chemoemolization using DEBIRI for Liver metases from Colorectal Cancer. Gastroenterol Res Pract. 2015; 2015:715102 AlShaalan R, Aljiffry M, Al-Busafi S, Metrakos P, Hassanain M. Saudi J. Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis. Gastroenterol. 2015 Mar-Apr; 21(2):64-70. Hassanain M, Simoneau E, Madkhali A, Al-Saati N, Aljiffry M, Tchervenkov J, Barkun J, Metrakos P. Post-transplant liver function score as an early surrogate marker of long-term outcome. Ann Transplant. 2015 Apr 9; 20 :198-205. Andrei AZ, Hall A, Smith AL, Bascuñana C, Malina A, Connor A, Altinel-Omeroglu G, Huang S, Pelletier J, Huntsman D, Gallinger S, Omeroglu A, Metrakos P, Zogopoulos G. Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose)polymerase-1/2 inhibitor BMN 673. Cancer Lett. 2015 Aug 1; 364(1):8-16. Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, BouganimN, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G. Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Curr Oncol. 2015 Apr; 22(2):113-21. Sebastiani G, Alshaalan R, Wong P, Rubino M, Salman A, Metrakos P, Deschenes M, Ghali P. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis . PLoS One. 2015 Jun 17; 10(6) Simoneau E, Hassanain M, Shaheen M, Aljiffry M, Molla N,Chaudhury P, Anil S, Khashper A, Valenti D, Metrakos P. Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases. Br J Surg. 2015 Sep; 102(10):1240-9. Bhat M, Skill N, Marcus V, Deschenes M, Tan X, Bouteaud J, Negi S, Awan Z, Aikin R, Kwan J,Amre R, Tabaries S, Hassanain M, Seidah NG, Maluccio M, Siegel P, Metrakos P. Decreased PCSK9 expression in human hepatocellular carcinoma.BMC Gastroenterol. 2015 Dec 16; 15:176.

Rho YS, Barrera I, Metrakos P, Kavan P. Complete Resolution of Metastatic Gallbladder Cancer after Standard Gemcitabine-Cisplatin Combination Therapy. Cureus 2015 Dec 17; 7(12). MICHEL, R A.L. Smith, A.L., Bascuñana, C., Hall, A., Salman, A., Andrei, A.Z., Volenik, A., Rothenmund, H. Ferland,D., Lamoussenery, D., Kamath, A.S., Amre, R. Caglar, D. Gao, Z.H., Haegert, D.G. Kanber, Y., Michel, R.P., Omeroglu-Altinel, G. Asselah, J. Bouganim, N., Kavan, P., Arena, G., Barkun, J. Chaudhury, P., Gallinger, S., Foulkes, W.D., Omeruglu, A., Metrakos, P., Zogopoulos, G. Establishment of a clinic-based pancreatic cancer and peri-ampullary tumour research registry in Quebec. Curr. Oncol. 22(2):113-21, 2015. Chen, Y-I., Paci, P., Michel, R.P., Bessissow, T. Myeloid sarcoma of the duodenum: a rare cause of

bowel obstruction and gastrointestinal bleeding. Endoscopy. 47 Suppl 1 UCTN: E181-2, 2015.

NGUYEN, VH Moreau B, Nguyen VH, Abish S and Sigman T. An Unusual Presentation of a Pediatric Gastrointestinal Stromal Tumor (GIST) Ann Pediatr Child Health 2015. 3 p1047 Zahedi O, Sissons W, Nguyen VH, Zargham R and Jaffarian F. Linear atrophoderma of Moulin: an underrecognized entity. Pediatr Rheumatol 2015 Oct 6; 13(1): p39. (doi: 10.1186/s12969-015-0036-6)

OMEROGLU, A

Dupuy F, Tabariès S, Andrzejewski S, Dong Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, Clemons M, Aguilar-Mahecha A, Basik M, Vincent EE, St-Pierre J, Jones RG, Siegel PM. PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer. Cell Metab. 2015 Oct 6; 22(4):577-89. doi: 10.1016/j.cmet.2015.08.007. Epub 2015 Sep 10.

AlSharif S, Meguerditchian A, Omeroglu A, Lamarre P, Altinel G, Mesurolle B. Pilomatricoma of the male breast: sonographic mammographic MRI features with pathologic correlation. Clin Imaging. 2015 Mar-Apr; 39(2):308-10. doi: 10.1016/j.clinimag.2014.07.005

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SNFNAC study. J Clin Oncol. 2015 Jan 20; 33(3):258-64. doi: 10.1200/JCO.2014.55.7827

Andrei AZ, Hall A, Smith AL, Bascuñana C, Malina A, Connor A, Altinel-Omeroglu G, Huang S, Pelletier J, Huntsman D, Gallinger S, Omeroglu A, Metrakos P, Zogopoulos G. Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673. Cancer Lett. 2015 Aug 1; 364(1):8-16. doi: 10.1016/j.canlet.2015.04.003. Epub 2015 Apr 9.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G. Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Curr Oncol. 2015 Apr; 22(2):113-21. doi: 10.3747/co.22.2300.

Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C. Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis. Onco Targets Ther. 2015 Apr 21; 8:911-9. doi: 10.2147/OTT.S71089. eCollection 2015.

OMEROGLU-ALTINEL AlSharif S, Meguerditchian A, Omeroglu A, Lamarre P, Altinel G, Mesurolle B. Pilomatricoma of the male breast: sonographic mammographic MRI features with pathologic correlation. Clin Imaging. 2015 Mar-Apr; 39(2):308-10. doi: 10.1016/j.clinimag.2014.07.005

Andrei AZ, Hall A, Smith AL, Bascuñana C, Malina A, Connor A, Altinel-Omeroglu G, Huang S, Pelletier J, Huntsman D, Gallinger S, Omeroglu A, Metrakos P, Zogopoulos G. Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673. Cancer Lett. 2015 Aug 1; 364(1):8-16. doi: 10.1016/j.canlet.2015.04.003. Epub 2015 Apr 9.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G. Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Curr Oncol. 2015 Apr; 22(2):113-21. doi: 10.3747/co.22.2300.

Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C. Pilot study investigating the prognostic significance of thymidine phosporylase expression in patients with metastatic breast cancer: a single institution retrospective analysis. Onco Targets Ther. 2015 Apr 21; 8:911-9. doi: 10.2147/OTT.S71089. eCollection 2015.

PAPADOPOULOS, V Martinez–Arguelles DB, Papadopoulos V (2015) Identification of hot spots of DNA methylation in the adult male adrenal in response to in utero exposure to the ubiquitous endocrine disruptor plasticizer di-(2-ethylhexyl) phthalate. Endocrinology, 156:124-133. Issop L, Fan J, Lee S, Rone MB, Basu K, Mui J, Papadopoulos V (2015) Mitochondria associated membrane formation in hormone-stimulated Leydig cell steroidogenesis: Role of ATAD3. Endocrinology, 156:334-345. Sakai M, Martinez-Arguelles DM, Patterson NH, Chaurand P, Papadopoulos V (2015) In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth. PLOS One, 10(3):e0120670.

Martinez–Arguelles D, Papadopoulos V (2015) Mechanisms mediating environmental chemical-induced endocrine disruption in the adrenal gland. Frontiers in Endocrinology, 6:29. Papadopoulos V, Aghazadeh Y, Fan J, Campioli, E., Zirkin BR, Midzak A (2015) Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis. Molecular & Cellular Endocrinology, 408:90-98. Campioli E, Duong TB, Deschamps F, Papadopoulos V (2015) Cyclohexane-1, 2-dicarboxylic acid diisononyl ester and metabolite effects on rat epididymal stromal vascular fraction differentiation of adipose tissue. Environmental Research, 140:145-156. (Erratum; Environmental Research, 2016, 144:170-171). Beattie MC, Adekola L, Papadopoulos V, Chen H, Zirkin BR (2015) Leydig cell aging and hypogonadism. Experimental Gerontology, 68:87-91. Midzak AS, Akula N, Rone MB, Papadopoulos V (2015) Computational modeling and biological validation of novel non-steroidal ligands for the cholesterol recognition /interaction amino acid consensus (CRAC) motif of the mitochondrial translocator protein (TSPO). Pharmacological Research, 99C:393-403. Mavrogonatou E, Papadimitriou K, Urban JP, Papadopoulos V, Kletsas K (2015) Deficiency in the α1 subunit of Na+/K+-ATPase enhances the anti-proliferative effect of high osmolality in nucleus pulposus intervertebral disc cells. Journal of Cell Physiology, 230:3037-3048. Midzak A, Denora N, Laquintana V, Cutrignelli A, Lopedota A, Franco M, Altomare CD, Papadopoulos V (2015) 2-phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse Leydig tumor cell line. European Journal of Pharmaceutical Sciences, 76:231-237. Chen H, Guo J, Ge R, Papadopoulos V, Zirkin BR (2015) Steroidogenic fate of the Leydig cells that repopulate the testes of young and aged Brown Norway rats after elimination of the preexisting Leydig cells. Experimental Gerontology, 72:8-15. Fan J, Midzak A, Campioli E, Culty M, Papadopoulos V (2015) Conditional steroidogenic cell-targeted deletion of the translocator protein (TSPO, 18-kDa) unveil its crucial role in viability and hormone-dependent steroid formation. Proceedings of the National Academy of Sciences (USA), 112:7261-7266. Li J and Papadopoulos V (2015) Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis. Biochemical Pharmacology, 97:99-110. Li J, Papadopoulos V, Veera V (2015) Steroid biosynthesis in adipose tissue. Steroids, 103:89-104. Culty M, Liu Y, Manku G, Chan WY, Papadopoulos V (2015) Expression of steroidogenesis-related genes in murine male germ cells. Steroids, 103:105-114. Sakai M, Elhilali M, Papadopoulos V (2015) The GnRH antagonist Degarelix directly inhibits benign prostate hyperplasia cell growth. Hormone & Metabolic Research, 47:925-931.

Azarashvili T, Krestinina O, Baburina Y, Odinokova I, Grachev D, Papadopoulos V, Akatov V, Lemasters J, Reiser G (2015) Combined effect of G3139 and TSPO ligands on Ca2+-induced permeability transition in rat brain mitochondria. Archives of Biochemistry and Biophysics, 587:70-77. Herrera-Rivero M, Heneka M, Papadopoulos V (2015) Translocator protein and new targets for neuroinflammation. Clinical and Translational Imaging, 3:391-402.

PARK, M Havrylov S. and Park M. MS/MS-based strategies for proteomic profiling of invasive cell structures. Proteomics 2015 Jan;15(2-3):272-86. You L, Zou J, Zhao H, Bertos NR, Park M, Wang E, Yang XJ. Deficiency of the chromatin regulator BRPF1 causes abnormal brain development. J Biol Chem. 2015 Mar 13;290(11):7114- 29. Ioannou MS, Bell ES, Girard M, Chaineau M, Hamlin JN, Daubaras M, Monast A, Park M, Hodgson L, McPherson PS. DENND2B activates Rab13 at the leading edge of migrating cells and promotes metastatic behavior. J Cell Biol. 2015 Mar 2;208(5):629-48. You L, Yan K, Zou J, Zhao H, Bertos NR, Park M, Wang E, Yang XJ. The chromatin regulator Brpf1 regulates embryo development and cell proliferation. J Biol Chem. 2015 May 1;290(18):11349-64. You L., Yan K., Zou J., Zhao H., Bertos N.R., Park M., Wang E. and Yang X-J. The lysine acetyltransferase

activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors. PLoS

Genetics. 2015 Mar 13; 290(11):7114-29.

Tabariès S, Annis MG, Hsu BE, Tam CE, Savage P, Park M, Siegel PM. Lyn modulates Claudin-2 expression

and is a therapeutic target for breast cancer liver metastasis. Oncotarget. 2015 Apr 20; 6(11):9476-87.

Li R, Knight J.F., Park M. and Pendergast, AM. Abl Kinases Regulate HGF/Met Signaling Required for

Epithelial Cell Scattering, Tubulogenesis and Motility. PLoS ONE, 2015 May 6; 10(5).

Oh, E-Y, Christensen, S.M., Ghanta, S., Jeong, J.C. Bucur, O., Glass, B., Montaser-Kouhsan, L.,

Knoblauch, N.W., Bertos, N., Saleh, S.M., Haibe-Kains, B., Park M., Beck, A.H. Extensive rewiring of

epithelial-stromal co-expression networks in breast cancer. Genome Biology 2015 Jun 19; 16:128.

Mui MZ, Zhou Y, Blanchette P, Chughtai N, Knight JF, Gruosso T, Papadakis AI, Huang S, Park M,

Gingras AC, Branton PE. The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase

Regulators of the Hippo Signaling Pathway. J Virol. 2015 Sep 1;89(17):8855-70.

Caserta E, Egriboz O, Wang H, Martin C, Koivisto C, Pecót T, Kladney RD, Shen C, Shim KS, Pham T,

Karikomi MK, Mauntel MJ, Majumder S, Cuitino MC, Tang X, Srivastava A, Yu L, Wallace J, Mo X,

Park M, Fernandez SA, Pilarski R, La Perle KM, Rosol TJ, Coppola V, Castrillon DH, Timmers C, Cohn

DE, O'Malley DM, Backes F, Suarez AA, Goodfellow P, Chamberlin HM, Macrae ER, Shapiro CL,

Ostrowski MC, Leone G. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer

development in vivo. Genes Dev. 2015 Aug 15;29(16):1707-20.

Li J, Davidson D, Martins Souza C, Zhong MC, Wu N, Park M, Muller WJ, Veillette A. Loss of PTPN12

Stimulates progression of ErbB2-dependent breast cancer by enhancing cell survival, migration, and

epithelial-to-mesenchymal transition. Mol Cell Biol. 2015 Dec 1; 35(23):4069-82.

PELMUS, M

Marques M, Beauchamp MC, Fleury H, Laskov I, Qiang S, Pelmus M, Provencher D, Mes-Masson AM,

Gotlieb WH, Witcher M. Chemotherapy reduces PARP1 in cancers of the ovary: implications for future

clinical trials involving PARP inhibitors. BMC Med, 2015, 9(13):217

RICHARDSON, J

Giordano C, Mojumdar K, Liang F, Li T, Richardson J, Divanghi M, et al.Toll-like receptor 4 ablation in mdx

mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum Mol Genet

2015 Apr 15; 24(8): 2147-62.

ROCHON, L

Varshney R, Forest VI, Mascarella MA, Zawawi F, Rochon L, Hier MP, Mlynarek A, Tamilia M, Payne RJ: The McGill thyroid nodule score, Does it help with indeterminate thyroid nodules? J Otolaryngol Head Neck Surg. 2015 Feb 3; 44(1):2. doi: 10.1186/s40463-015-0058-6.

TELLERIA, C

Goyeneche AA, Koch M, Bell MC, Telleria CM (2015). Long term primary culture of a clear cell ovarian

carcinoma reveals an epithelial-mesenchymal cooperative interaction. Cancer Cell International 15:88.

Ghersa F, Burdizzo J, Vallcaneras S, Fuentes F, de la Vega M, Delgado SM, Telleria CM, and Casais M.

(2015) Neuro-modulation of the luteal regression: presence of progesterone receptors in coeliac ganglion.

Experimental Physiology; 100: 935-946

Goyeneche AA, Telleria CM (2015). Antiprogestins in gynecological diseases. Reproduction 149: R15-R33.

VANKEMPEN, L

Rivera B, Castellsagué E, Bah I, van Kempen LC, Foulkes W. Biallelic NTHL1 Mutations in a Woman with Multiple Primary Tumors. New Eng J Med. 2015; 373:1985-1986

Lagabrielle S, Janssen S, Elchebly M, Bladou F, Spatz A, Van Kempen L. PAX6 est un modulateur de l'activité transcriptionnelle du récepteur aux androgènes dans le cancer de prostate. Prog Urol. 2015 Nov;25(13):735. Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L: A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nat Commun. 2015; 6:8093.

El Hajj P, Gilot D, Migault M, Theunis A, van Kempen LC, Salés F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F. SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. Br J Cancer. 2015; 113(1):91-8.

Zhan Y, Dahabieh MS, Rajakumar A, Dobocan MC, M'Boutchou MN, Goncalves C, Shiru L L, Pettersson F, Topisirovic I, van Kempen L, Del Rincón SV, Miller Jr WH: The role of eIF4E in response and acquired resistance to Vemurafenib in melanoma. J Invest Dermatol. 2015 135(5):1368-76.

Jamal R, van Kempen L, Thebault P, Belanger K, Friedmann JE, Ayoub J-PM, Cocolakis E, Kazemi S, Dionne J, Lamber C, HB Le,Grange C, Cailhier J-F, Spatz A,Lapointe R, Miller WH: One0year overall survival (OS) and biomarker correlates from a phase II study of of ipilimimab (IPI) with carboplatin and paclitaxel (CP) in patienst with unresectable stage III or IV metastatic melanoma (MM). J Clin Oncol 33, 2015 (suppl; abstr 9062).

WANG, H

Kiess AP, Wang H, Travis WD and Yahalom J. Sarcoid in cancer patients: clinical characteristics and

associated disease status. Vasc Diffuse Lung dis. 2015 Sep 14; 32(3):200-7.